Replies to post #130260 on Anavex Life Sciences Corp (AVXL)

[LakeshoreLeo1953]

Even RECORD application (and a restrictive pool Anavex is seeking to improve response) still puts a CRO 6 months down the road from initiation.

If previous P2 had as PRIMARY end point safety, what (other than significant "super response" leads one to conclude that the efficacy endpoint will be anywhere near that length of time? That brings one to Jan 2019 AT BEST.

There are emerging catalysts which MAY change the funding equation, but
2019 at minimum....new rules or not....is pretty much a given for results.